Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 3/2007

01.09.2007 | Original Article

Are nuchal translucency, pregnancy associated plasma protein-A or free-β-human chorionic gonadotropin depending on maternal age? A multicenter study of 8,116 pregnancies

verfasst von: Peter Schmidt, Michael Pruggmayer, Andrea Steinborn, Cordula Schippert, Ismini Staboulidou, Peter Hillemanns, Alexander Scharf

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

Introduction

First-trimester screening according to Nicolaides uses maternal age to obtain a common background risk for trisomy 21. The likelihood ratios by nuchal translucency, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A are not with respect to maternal age. It was the aim of this study to investigate if likelihood ratios should better take care of it.

Materials

Pearson’s correlation and different models of regression analysis had been performed on the results of 8,116 first-trimester screenings. The total number of pregnancies was subdivided into three subgroups of healthy fetuses (n = 8,038); fetuses with Down’s syndrome (n = 46) and fetuses with other genetic abnormalities (n = 32). Statistical testing was applied to each of the three groups.

Results

Strong independence from maternal age could be found for each of the first-trimester screening measurement parameter, as well for healthy and as for affected fetuses. Neither Pearson’s test nor nonlinear regression models could detect a correlation. Accordingly significance of Pearson’s test is not given.

Discussion

First-trimester screening would not be improved by considering the maternal age in the calculation of the likelihood ratios. Therefore the currently used algorithm is adequate. According, to the results, it seems to be proper as well to disregard the maternal age in newer test strategies advanced first-trimester screening (AFS) at all.
Literatur
1.
Zurück zum Zitat Biagotti R, Petri E, Cariati E (1994) Humerus and femur length in fetuses with Down syndrome pregnancies. Obstet Gynecol 84:844–847 Biagotti R, Petri E, Cariati E (1994) Humerus and femur length in fetuses with Down syndrome pregnancies. Obstet Gynecol 84:844–847
2.
Zurück zum Zitat Bromley B, Doubilet P, Frigoletto FD Jr, Krauss C, Estroff JA, Benacerraf BR (1994) Is fetal hyperechoic bowel on second-trimester sonogram an indication for amniocentesis? Obestet Gynecol 83:647–651 Bromley B, Doubilet P, Frigoletto FD Jr, Krauss C, Estroff JA, Benacerraf BR (1994) Is fetal hyperechoic bowel on second-trimester sonogram an indication for amniocentesis? Obestet Gynecol 83:647–651
3.
Zurück zum Zitat Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides KH (2001) Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study. Lancet 358:1665–1667PubMedCrossRef Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides KH (2001) Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study. Lancet 358:1665–1667PubMedCrossRef
4.
Zurück zum Zitat Krampl E, Wertaschnigg D, Husslein P (2002) Down-syndrom-Screening im ersten Trimenon. Geburtshilfe Frauenheilk 62 (9):843–848CrossRef Krampl E, Wertaschnigg D, Husslein P (2002) Down-syndrom-Screening im ersten Trimenon. Geburtshilfe Frauenheilk 62 (9):843–848CrossRef
5.
Zurück zum Zitat Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D’Alton ME (2005) First- and second-trimester evaluation of risk (FASTER) research consortium. First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med 353(19):2001–2011PubMedCrossRef Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D’Alton ME (2005) First- and second-trimester evaluation of risk (FASTER) research consortium. First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med 353(19):2001–2011PubMedCrossRef
6.
Zurück zum Zitat Nicolaides KH, Sebire N, Snijders RJM (1999) Die Ultraschalluntersuchung der Schwangerschaftswoche. Pathenon Publishing, Birmingham, pp 11–14 Nicolaides KH, Sebire N, Snijders RJM (1999) Die Ultraschalluntersuchung der Schwangerschaftswoche. Pathenon Publishing, Birmingham, pp 11–14
7.
Zurück zum Zitat Schmidt P, Scharf A (2006) Advanced first-trimester screening—a critical review of the fundamental studies and suggestions for improvement. Geburtsh Frauenheilk 67:S1–S183 Schmidt P, Scharf A (2006) Advanced first-trimester screening—a critical review of the fundamental studies and suggestions for improvement. Geburtsh Frauenheilk 67:S1–S183
8.
Zurück zum Zitat Schmidt P, Staoulidou I, Soergel P, Hillemanns P, Scharf A Advanced first trimester screening (AFS): an improved test strategy for the individual risk assessment of fetal aneuploidies and malformations. Arch Obstet Gynecol (in press) Schmidt P, Staoulidou I, Soergel P, Hillemanns P, Scharf A Advanced first trimester screening (AFS): an improved test strategy for the individual risk assessment of fetal aneuploidies and malformations. Arch Obstet Gynecol (in press)
9.
Zurück zum Zitat Schuchter K, Wald N, Hackshaw AK, Hafner E, Liebhart E (1998) The distribution of nuchal translucency at 10–13 weeks of pregnancy. Prenat Diagn 18:281–286PubMedCrossRef Schuchter K, Wald N, Hackshaw AK, Hafner E, Liebhart E (1998) The distribution of nuchal translucency at 10–13 weeks of pregnancy. Prenat Diagn 18:281–286PubMedCrossRef
10.
Zurück zum Zitat Simpson JM, Cook A, Sharland G (1996) The significance of echogenic foci in the fetal heart: a preospective study of 228 cases. Ultrasound Obstet Gynecol 8:225–228PubMedCrossRef Simpson JM, Cook A, Sharland G (1996) The significance of echogenic foci in the fetal heart: a preospective study of 228 cases. Ultrasound Obstet Gynecol 8:225–228PubMedCrossRef
11.
Zurück zum Zitat Snijders RJM, Shawa L, Nicolaides KH (1994) Fetal choroid plexus cysts and trisomy 18: assessment of risk based on ultrasound findings and maternal age. Prenat Diagn 14:1119–1127PubMedCrossRef Snijders RJM, Shawa L, Nicolaides KH (1994) Fetal choroid plexus cysts and trisomy 18: assessment of risk based on ultrasound findings and maternal age. Prenat Diagn 14:1119–1127PubMedCrossRef
12.
Zurück zum Zitat Snijders RJM , Noble P, Sebire N, Souka A, Nicolaides KH (1998) UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation. Lancet 351:343–346CrossRef Snijders RJM , Noble P, Sebire N, Souka A, Nicolaides KH (1998) UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation. Lancet 351:343–346CrossRef
13.
Zurück zum Zitat Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, Platt L, Mahoney M, Johnson A, Hogge WA, Wilson RD, Mohide P, Hershey D, Krantz D, Zachary J, Snijders R, Greene N, Sabbagha R, MacGregor S, Hill L, Gagnon A, Hallahan T, Jackson L (2003) First-trimester screening for trisomy-21 and 18. N Engl J Med 349:1405–1413PubMedCrossRef Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, Platt L, Mahoney M, Johnson A, Hogge WA, Wilson RD, Mohide P, Hershey D, Krantz D, Zachary J, Snijders R, Greene N, Sabbagha R, MacGregor S, Hill L, Gagnon A, Hallahan T, Jackson L (2003) First-trimester screening for trisomy-21 and 18. N Engl J Med 349:1405–1413PubMedCrossRef
14.
Zurück zum Zitat Wickstrom EA, Thangavelu M, Parilla BV, Tamura RK, Sabbagha RE (1996) A prospective study of the association between isolated fetal pyelectasis and chromosomal abnormality. Obstet Gynecol 88:379–382PubMedCrossRef Wickstrom EA, Thangavelu M, Parilla BV, Tamura RK, Sabbagha RE (1996) A prospective study of the association between isolated fetal pyelectasis and chromosomal abnormality. Obstet Gynecol 88:379–382PubMedCrossRef
Metadaten
Titel
Are nuchal translucency, pregnancy associated plasma protein-A or free-β-human chorionic gonadotropin depending on maternal age? A multicenter study of 8,116 pregnancies
verfasst von
Peter Schmidt
Michael Pruggmayer
Andrea Steinborn
Cordula Schippert
Ismini Staboulidou
Peter Hillemanns
Alexander Scharf
Publikationsdatum
01.09.2007
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2007
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-007-0342-4

Weitere Artikel der Ausgabe 3/2007

Archives of Gynecology and Obstetrics 3/2007 Zur Ausgabe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.